Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
New medicines and vaccines save lives and help make our healthcare system more cost‑effective.
Preventing or curing disease means extending lives, relieving suffering and improving people’s quality of life.
Promoting a robust regulatory protocol means ensuring safe and effective medicines for Canadians.
Supporting sustainable healthcare means we all spend more time enjoying life and being productive.
Innovative Medicines Canada members
High-quality jobs
Total yearly economic impact
For the second year in a row,
we saw considerable growth
in the number of claimants
with an 8.5% increase, making
it the main driver of overall
cost. This increase in claimants
was balanced by a low single
digit increase in the cost per
claimants of 2.7%. Read the full report.
This study examines the contribution of the Canadian research and development (R&D) pharmaceutical sector on the Canadian economy in 2021. […]
In many areas of high unmet patient need, early access to new medicines through clinical trials are the only option for Canadian patients. There are over 3,000 ongoing clinical trials in Canada which provide significant value to patients. Early access to innovative treatments improves health outcomes, increases quality of life, and gives hope to patients and their loved ones. Clinical trials also provide value to our healthcare system, research ecosystem, and economy.
Press Release October 11, 2024
With the passage of the Pharmacare Act, Innovative Medicines Canada remains concerned that the pharmacare program as outlined in the […]
Press Release October 03, 2024
“Minister Holland’s recent letter to SOCI regarding the impact of Bill C-64 on private insurance in Canada confirms our concerns: […]
Press Release September 25, 2024
Ottawa, September 25, 2024 – Innovative Medicines Canada (IMC) welcomes the announcement of the federal government’s commitment to safeguarding the […]
Press Release July 24, 2024
Ottawa, July 24, 2024 – Innovative Medicines Canada (IMC) is encouraged by the announcement that the federal government and the […]
Press Release July 17, 2024
Ottawa, July 17, 2024 – Innovative Medicines Canada (IMC) is committed to working with and supporting provincial governments to ensure […]
Press Release June 13, 2024
Ottawa, June 13, 2024 – This week, Statistics Canada published new data that demonstrates the important impact the innovative pharmaceutical […]
Press Release May 06, 2024
Nominate a researcher who has advanced diversity and equity in Canada by August 1,2024 Ottawa, May 6, 2024 – The […]
Press Release April 24, 2024
Nominate outstanding contributions to health sciences, policy, and research by July 15, 2024.
Informative content to keep you up to date on the most pressing issues facing our industry.
